egative inotropic agents, such as -blockers or class Ia antiarrhythmic drugs, are effective in alleviating symptoms and the left ventricular pressure gradients in patients with hypertrophic obstructive cardiomyopathy. [1] [2] [3] [4] [5] We previously reported on the efficacy of the class Ia antiarrhythmic drug disopyramide for the muscular right ventricular outflow tract (RVOT) obstruction associated with tetralogy of Fallot (TF). 6 However, the precise hemodynamic changes have not been investigated. Furthermore there is no data on how disopyramide influences right ventricular performance in patients with TF. So we investigated the hemodynamic and right ventricular volumetric effects of disopyramide, based on the hypothesis that it should relieve hypoxia in patients with TF.
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Methods

Subjects
We analyzed 11 consecutive patients with TF, whose ages ranged from 3 to 43 (24±14, mean ± SD) months and whose body weight varied from 3.5 to 15.5 (9.5±3.2) kg (Table 1) . Although the severity of the RVOT obstruction differed in each patient, all patients had both valvular and muscular obstruction. Seven of them had not had any previous surgery (Table 1 , cases 1-7), but the others had undergone a systemic-pulmonary shunt (Table 1 , cases [8] [9] [10] [11] . All but one patient without previous surgery had had oral medication with a -blocker, either propranolol or carteolol, to prevent hypercyanotic spells. Permission for the administration of disopyramide was obtained from their parents and the study protocol was approved by the institutional ethics committee.
Hemodynamic Parameters
In the 7 patients without previous surgery, we measured the following hemodynamic parameters: aortic oxygen saturation, ascending aorta and main pulmonary artery systolic pressures, and the systolic peak-to-peak pressure gradient between the main pulmonary artery and the right ventricle. Systemic and pulmonary blood flows and vascular resistances were calculated using Fick's method, oxygen consumption being derived from the LaFarge's formula. 7 Heart rate, right ventricular volume, and the diameter of the RVOT were analyzed in these patients and in the other 4 patients with a previous systemic-pulmonary shunt. Under sedation after an intravenous injection of thiopental and/or midazolam, a standard right-and leftheart catheterization was performed using a fluid-filled catheter system. Right ventriculography was performed in the anteroposterior and lateral projections with a film speed of 60 frames/s. Pressures were measured using a Statham P23XL transducer and blood oxygen saturations were analyzed with an OSM 2 Hemoximeter (Radiometer, Copenhagen, Denmark). Diastolic and systolic right ventricular volumes were measured by the biplane integral method and corrected according to the method of Graham et al. 8 In all patients, the pulmonary artery was entered antegradely, and the ascending aorta via the ventricular septal defect. The narrowest internal diameter of the RVOT was measured from the lateral projection of the right ventriculogram at end-diastole and end-systole. Magnification was corrected using a grid positioned similarly to the patient. Right ventricular volumes and the diameter of the RVOT were indexed by correction for the patient's body surface Jpn Circ J 1999; 63: 160 -164 (Received September 10, 1998 ; revised manuscript received December 9, 1998 ; accepted December 11, 1998 The hemodynamic and right ventricular volumetric effects of disopyramide were investigated in patients with tetralogy of Fallot (TF). Intracardiac pressure and oxygen saturation were measured, before and after intravenous administration of disopyramide (2 mg/kg) in 7 patients who had not had previous surgery. Right ventricular volume and the diameter of its outflow tract were analyzed in these 7 and in a further 4 patients with a previous shunt. Aortic oxygen saturation increased from 90.4±7.5 (mean ± SD) to 94.1±5.5% (p<0.05) with an increase in pulmonary blood flow and pressure. The systolic pressure gradient between the main pulmonary artery and the right ventricle decreased from 59±8 to 42±9 mmHg (p<0.01). area. These measurements were repeated 5 min after the intravenous administration of disopyramide (2 mg/kg). For hemodynamic parameters that altered significantly after the administration of disopyramide, we analyzed the correlations between their percent changes, calculated using the following formula: (before disopyramide -after disopyramide) × 100 / before disopyramide, and the resting diastolic diameter of the RVOT and pulmonary artery index. 9 
Statistical Analysis
Statistical analysis was done using a paired t-test and a simple regression test (Stat View 4.5 software). A p-value less than 0.05 was taken as significant.
Results
Aortic oxygen saturation increased from 78.0-99.6 (90.4±7.5, mean ± SD) to 86.0-99.9 (94.1±5.5)% (p<0.05). Aortic pressures fell slightly from 68-83 (77±5) to 63-70 (67±4) mmHg (p<0.05). The pulmonary artery pressure rose from 14-35 (23±7) to 19-47 (32±10) mmHg (p<0.01). The pull back systolic pressure gradient between the main pulmonary artery and the right ventricle decreased from 49-69 (59±8) to 27-53 (42±9) mmHg (p<0.01). Systemic blood flow fell from 2.9-4.6 (3.6±0.6) to 2.0-3.3 (2.5±0.5) L min -1 m -2 (p<0.01). In contrast, pulmonary blood flow increased from 1.8-8.3 (3.9±2.3) to 2.9-9.8 (4.8±2.6) L min -1 m -2 (p<0.01). Consequently systemic vascular resistance increased from 12.7-18.3 (15.3±2.2) to 13.9-22.5 (19.4±3.3) u · m 2 (p<0.05), whereas pulmonary vascular resistance remained unchanged (Table 2) .
Heart rate tended to increase slightly, without statistical significance. There was no significant change in the right ventricular end-diastolic volume index, though the endsystolic volume index increased from 5.2-30.5 (19.7±7.0) to 12.2-49.6 (30.0±12.3) ml/m 2 (p<0.01). As a result, the right ventricular ejection fraction decreased from 52.2- 77.0 (64.3±7.9) to 20.9-68.0 (47.2±13.5)% (p<0.01). Both the diastolic and the systolic diameter indices of the RVOT increased from 12. Fig 1) . Percent change in aortic oxygen saturation had a significant negative correlation with the resting diastolic diameter index of the RVOT (r=-0.85, p<0.05). No other significant correlations were found between percent changes of hemodynamic parameters and the resting diastolic diameter index of the RVOT or the pulmonary artery index. (Table 3) .
There were no serious side effects from the disopyramide administration.
Discussion
Intracardiac repair for TF is increasingly performed in younger patients with satisfactory results. Several groups have reported that single stage intracardiac repair in early infancy results in a better outcome than the conventional 2-stage approach of repair preceded by a systemic-pulmonary shunt. [10] [11] [12] [13] [14] Although early repair has decreased the frequency of severe hypercyanotic spells, such spells may occasionally complicate cardiac catheterization or occur in other situations, with a potentially lethal outcome. Conventional medical treatment of hypercyanotic spells includes sedatives (to reduce oxygen consumption), sodium bicarbonate (to correct metabolic acidosis), -blockers (to relieve infundibular spasm) and -stimulants (to increase left-to-right shunt by raising systemic vascular resistance). 15, 16 However, these medications occasionally fail to relieve severe hypoxia and emergency palliative surgery or intracardiac repair becomes necessary. The weak negative inotropic action of -blockers minimally increases arterial oxygen saturation at rest, 17 although they do not prevent a drop in arterial oxygen saturation during exercise and have no beneficial effects on exercise capacity in patients with TF. 18 Furthermore they have potentially adverse actions, such as their negative chronotropic and hypotensive effects that may decrease left-to-right shunting.
There are several reports that the class Ia antiarrhythmic drugs such as disopyramide or cibenzoline, which has a more potent negative inotropic action than propranolol, may alleviate the left ventricular outflow tract obstruction of hypertrophic obstructive cardiomyopathy that is refractory to -blockers. [1] [2] [3] [4] [5] We investigated the effects of disopyramide on the hemodynamics, right ventricular performance, and the diameter of the RVOT in patients with TF at rest. Because vascular resistance and ventricular pump function are major factors that determine both the blood flow volume through a systemic-pulmonary shunt and systemic oxygen saturation, we analyzed the hemodynamic changes, such as blood flow and vascular resistance, only in patients without a previous systemic-pulmonary shunt. Right ventricular volume and the diameter of the RVOT were examined in a total of 11 patients, including 4 who had had a previous systemic-pulmonary shunt. Intravenous administration of disopyramide (2 mg/kg) increased systemic oxygen saturation at rest with a consistent increase in pulmonary pressure and blood flow. The pressure gradient between the right ventricle and the pulmonary artery decreased.
A recent study of the left ventricular outflow tract obstruction in hypertrophic obstructive cardiomyopathy demonstrated that negative inotropic agents work not by altering the anatomical relationship between the mitral valve and the ventricular septum but by decreasing ejection acceleration and the hydrodynamic force on the protruding mitral leaflet. 19 In our study, there was no significant change in heart rate, right ventricular end-diastolic volume, and diastolic diameter of the RVOT. However, right ventricular end-systolic volume and the systolic diameter of the RVOT increased significantly. The right ventricular ejection fraction decreased. These results indicate that the potent negative inotropic action of disopyramide directly dilates the RVOT thereby increasing pulmonary blood flow. A slight but significant decrease in aortic pressure results from a decrease in the right to left shunt and left ventricular pump function. Although systemic vascular resistance increased significantly, an excessive dose may lead to a serious systemic low output and hypotension.
The efficacy of negative inotropic agents in hypoxia in TF patients depends on the morphology and severity of RVOT obstruction. Negative inotropic agents will likely be most effective in patients in whom muscular RVOT obstruction predominates and pulmonary valve and artery stenosis are mild. Although the small number of patients in this study is a limitation, the diastolic diameter of the RVOT corrected by body surface area seemed to be a major factor determining the efficacy of disopyramide.
Study Limitations
This study evaluated the hemodynamic effects of disopyramide at rest. Its efficacy in hypoxia in sympathotonic conditions should be investigated in a further study. Neither arrhythmias nor anticholinergic side effects were observed in this study. Further studies should be undertaken in a large patient group.
